INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.77B / 19S · 11 late96 trades$25.89M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 32S32 trades$5.48M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

70,589 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
GR
Gonzalez Lissette REVP, Chief Commercial Officer
BLMNBloomin' Brands, Inc.
Option exercise
M—
4,861 sh
Mar 3, 2026Mar 5, 2026
Page 1195 of 1765
← PrevNext →
traded Mar 3, 2026
+2d
SEC Form 4

Evidence

9
DS
Dewan SameerSenior Vice President
GGenpact LTD
Grant or award
A—
6,928 sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

9
SJ
Sumner Michael JohnChief Medical Officer
INOINOVIO PHARMACEUTICALS, INC.
Grant or award
A—
29.6K sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

9
BC
Brackmann ChristophChief Financial Officer
NVCRNovoCure Ltd
Grant or award
A—
80.7K sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

9
RK
Ruddy Marcella K.Chief Medical Officer
TECXTectonic Therapeutic, Inc.
Grant or award
A—
24.3K sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

8
WK
Williams Robert KirkChief People & Admin Officer
DFINDonnelley Financial Solutions, Inc.
Tax withholding
F$51K
954 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

8
KK
Kalia KumudChief Information Officer
GHGuardant Health, Inc.
Option exercise
M$74K
1,000 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

8
WC
Werner Edward CooperChief Financial Officer
FFIVF5, INC.
Open-market sale · 10b5-1 plan
SELL$60K
209 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

7
MP
McNamara PeterChief Scientific Officer
TECXTectonic Therapeutic, Inc.
Grant or award · 10b5-1 plan
A—
23.0K sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

6
SA
Steenberge Michael AnthonyChief Accounting Officer
PARPAR TECHNOLOGY CORP
Open-market sale · 10b5-1 plan
SELL$11K
582 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

6
MP
McNamara PeterChief Scientific Officer
TECXTectonic Therapeutic, Inc.
Open-market sale · 10b5-1 plan
SELL$41K
1,650 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

6
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$128K
2,937 sh
Mar 5, 2026Mar 5, 2026
traded Mar 5, 2026
+0dSEC Form 4

Evidence

6
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$72K
1,600 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

5
KK
Kalia KumudChief Information Officer
GHGuardant Health, Inc.
Option exercise
M—
10.0K sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

5
WC
Werner Edward CooperChief Financial Officer
FFIVF5, INC.
Open-market sale · 10b5-1 plan
SELL$23K
80 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

5
KK
Kalia KumudChief Information Officer
GHGuardant Health, Inc.
Option exercise
M—
2,119 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

5
RR
Renninger RobertCHIEF FINANCIAL OFFICER
LONALeonaBio, Inc.
Option exercise
M—
3,900 sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

5
WC
Werner Edward CooperChief Financial Officer
FFIVF5, INC.
Open-market sale · 10b5-1 plan
SELL$23K
80 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

5
KK
Kalia KumudChief Information Officer
GHGuardant Health, Inc.
Option exercise
M—
1,000 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

5
SD
Silva Effie DSVP, General Counsel & Secy
FDPDEL MONTE CORP
Option exercise
M—
151 sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

5
WC
Werner Edward CooperChief Financial Officer
FFIVF5, INC.
Open-market sale · 10b5-1 plan
SELL$11K
40 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

2
DB
Dechairo BryanChief Operating Officer
WGSGeneDx Holdings Corp.
Grant or award
A—
10.4K sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

2
FK
Feeley KevinCHIEF FINANCIAL OFFICER
WGSGeneDx Holdings Corp.
Grant or award
A—
10.9K sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

1
HM
Hopman MarkChief Commercial Officer
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$4,084
353 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

0
BM
Bick Karen M.SVP - Chief People Officer
RALRalliant Corp
Tax withholding · 10b5-1 plan
F$39K
841 sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

0
MP
McNamara PeterChief Scientific Officer
TECXTectonic Therapeutic, Inc.
Grant or award · 10b5-1 plan
A—
21.0K sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

0
RR
Ribeiro RamiroChief Medical Officer
EYPTEyePoint, Inc.
Option exercise · 10b5-1 plan
M—
2,438 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

0
BM
Bick Karen M.SVP - Chief People Officer
RALRalliant Corp
Tax withholding · 10b5-1 plan
F$34K
733 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

0
RR
Ribeiro RamiroChief Medical Officer
EYPTEyePoint, Inc.
Option exercise · 10b5-1 plan
M$20K
2,438 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

65
MF
Musser ForySenior VP, Development
VGVenture Global, Inc.
Open-market sale
SELL$10.90M
1.00M sh
Mar 4, 2026Mar 4, 2026
traded Mar 4, 2026
+0dSEC Form 4

Evidence

47
SC
Sorrentino CharlesDirector, Co-CIO
RPLRTRithm Perpetual Life Residential Trust
Open-market purchase
BUY$300K
14.9K sh
Mar 2, 2026Mar 4, 2026
traded Mar 2, 2026
+2dSEC Form 4

Evidence

44
MA
McMahon Stephen AEVP, Chief Customer Officer
DTDynatrace, Inc.
Open-market purchase
BUY$107K
3,000 sh
Mar 3, 2026Mar 4, 2026
traded Mar 3, 2026
+1dSEC Form 4

Evidence

43
CM
Carlson MeganCAO and SVP, Finance
BFLYButterfly Network, Inc.
Open-market sale
SELL$156K
42.0K sh
Mar 3, 2026Mar 4, 2026
traded Mar 3, 2026
+1dSEC Form 4

Evidence

42
DJ
Devivo JosephDirector, President & CEO
BFLYButterfly Network, Inc.
Open-market sale
SELL$599K
161.3K sh
Mar 3, 2026Mar 4, 2026
traded Mar 3, 2026
+1dSEC Form 4

Evidence

36
HM
Holt MichaelChief Financial Officer
MORNMorningstar, Inc.
Open-market purchase
BUY$187K
1,000 sh
Mar 4, 2026Mar 4, 2026
traded Mar 4, 2026
+0dSEC Form 4

Evidence

35
SE
Sparks Paul EugeneDirector
BWINBaldwin Insurance Group, Inc.
Open-market purchase
BUY$666K
29.0K sh
Mar 2, 2026Mar 4, 2026
traded Mar 2, 2026
+2dSEC Form 4

Evidence

35
CN
Caezza NicholasDeputy General Counsel
BFLYButterfly Network, Inc.
Open-market sale
SELL$53K
14.2K sh
Mar 3, 2026Mar 4, 2026
traded Mar 3, 2026
+1dSEC Form 4

Evidence

35
CS
Cashman SteveChief Business Officer
BFLYButterfly Network, Inc.
Open-market sale
SELL$158K
42.5K sh
Mar 3, 2026Mar 4, 2026
traded Mar 3, 2026
+1dSEC Form 4

Evidence

31
CG
Canup Edward GCHIEF BANKING OFFICER
CBANCOLONY BANKCORP INC
Open-market purchase
BUY$10K
500 sh
Feb 27, 2026Mar 4, 2026
traded Feb 27, 2026
+5dSEC Form 4

Evidence

31
VC
Vieira CoryChief Accounting Officer
PGYPagaya Technologies Ltd.
Open-market sale
SELL$27K
2,490 sh
Mar 2, 2026Mar 4, 2026
traded Mar 2, 2026
+2dSEC Form 4

Evidence